Mechanisms of drug resistance in chemotherapy for urogenital carcinoma
Open Access
- 1 September 1999
- journal article
- review article
- Published by Wiley in International Journal of Urology
- Vol. 6 (9) , 427-439
- https://doi.org/10.1046/j.1442-2042.1999.00088.x
Abstract
No abstract availableKeywords
This publication has 61 references indexed in Scilit:
- Circumvention of Multidrug Resistance in Genitourinary TumorsInternational Journal of Urology, 1998
- Testicular Germ-Cell CancerNew England Journal of Medicine, 1997
- Do cMOAT (MRP2), other MRP homologues, and LRP play a role in MDR?Seminars in Cancer Biology, 1997
- The physiological function of drug-transporting P-glycoproteinsSeminars in Cancer Biology, 1997
- Hepatocellular Transport: Role of ATP-Binding Cassette ProteinsSeminars in Liver Disease, 1996
- Expression of multidrug resistance-associated protein (MRP), MDR1 and DNA topoisomerase II in human multidrug-resistant bladder cancer cell linesBritish Journal of Cancer, 1995
- Disruption of the mouse mdr1a P-glycoprotein gene leads to a deficiency in the blood-brain barrier and to increased sensitivity to drugsPublished by Elsevier ,1994
- Overexpression of a Transporter Gene in a Multidrug-Resistant Human Lung Cancer Cell LineScience, 1992
- Internal duplication and homology with bacterial transport proteins in the mdr1 (P-glycoprotein) gene from multidrug-resistant human cellsCell, 1986
- Isolation of human mdr DNA sequences amplified in multidrug-resistant KB carcinoma cells.Proceedings of the National Academy of Sciences, 1986